



 |
Announcements OSTEOMED,
L.P. SELECTS CLINIVATION GLOBAL® XI. Leading
global innovator, developer, manufacturer and marketer of specialty medical devices,
surgical implants and powered surgical instruments selects clinivation Global
xi as the foundation for managing their global market clearance operations. Natick,
MA, December 29, 2008 - clinivation, Inc. announced today that OsteoMed,
L.P. has selected the clinivation Global xi enterprise solution for Market Clearance
Management.
"OsteoMed is an innovative global leader in the development
and production of medical devices, surgical implants and powered surgical instruments
and we are pleased that they have selected the clinivation Global xi Market Clearance
Platform as the foundation for managing their global market clearance operations,"
said Richard Morroney, R.A.C., C.Q.A., clinivation's Vice President of Quality
and Regulatory Solutions. About the clinivation Global
xi Market Clearance Platform The clinivation Global xi
enterprise solution for Market Clearance Management enables executives and their
teams to address the challenges of execution, effective governance, and lean business
performance in their global market clearance operations. By enabling excellence
in global market clearance operations to advance the revenue intrinsic to market
clearance success, clinivation Global xi liberates revenue that's trapped-in-process.
About OsteoMed, L.P. Headquartered
in Addison, Texas, OsteoMed, is a leading global innovator, developer, manufacturer
and marketer of specialty medical devices, surgical implants and powered surgical
instruments. The company's success is driven by its ability to develop and deliver
innovative, quality products that improve patient outcomes and offer technically
advanced, simple, and cost effective solutions for its surgeon and hospital customers.
The company specializes in small bone reconstruction and trauma surgical devices
targeted primarily to the Oral Maxillofacial, Neuro, Plastic Reconstructive, Otolaryngology
(ENT), upper and lower small bone surgical specialties. For more information,
please visit www.osteomedcorp.com.
About clinivation, Inc. Clinivation
is the leading provider of integrated solutions that enable global market clearance.
Guided by our singular vision - "Excellence in Market Clearance" - clinivation
accelerates the entire market clearance cycle to advance new worldwide revenue
and achieve new milestones of enterprise value. Used in over 1,000,000 product
registrations by more than 100 companies worldwide, clinivation's end-to-end technology
and services deliver on our vision by eliminating revenue traps from global market
clearance operations, increasing process velocity with on-demand regulatory intelligence,
automating clearance-driven business controls, simplifying content unification
into market clearance applications, aligning quality systems with global market
clearance priorities, streamlining clinical development with clearance-focused
trials, and enabling management with key performance indicators for continuous
improvement and effective governance. The world's leading medical device,
diagnostics, hospital supply, and dental supply companies select clinivation because
of our medtech industry focus and our unique, integrated solutions that seamlessly
adapt to existing business processes and enterprise infrastructure- without the
need to write custom code. Our core brands include the clinivation Global®
xi market clearance platform, clinivation WorldView® on-demand
regulatory intelligence, and clinivation Clinical Suite® and clinivation
Registry Suite® electronic data capture and clinical data management
software. Founded in 1999, the company is headquartered in Natick, Massachusetts,
with regional offices in North America and Asia. Visit clinivation online
at www.clinivation.com For
further information: For more information on clinivation's
integrated solutions that enable global market clearance, please click
here or call us at 508.655.6560. |